Article

A de novo paradigm for mental retardation

Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences and Institute for Genetic and Metabolic Disorders, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Nature Genetics (Impact Factor: 29.35). 11/2010; 42(12):1109-12. DOI: 10.1038/ng.712
Source: PubMed

ABSTRACT

The per-generation mutation rate in humans is high. De novo mutations may compensate for allele loss due to severely reduced fecundity in common neurodevelopmental and psychiatric diseases, explaining a major paradox in evolutionary genetic theory. Here we used a family based exome sequencing approach to test this de novo mutation hypothesis in ten individuals with unexplained mental retardation. We identified and validated unique non-synonymous de novo mutations in nine genes. Six of these, identified in six different individuals, are likely to be pathogenic based on gene function, evolutionary conservation and mutation impact. Our findings provide strong experimental support for a de novo paradigm for mental retardation. Together with de novo copy number variation, de novo point mutations of large effect could explain the majority of all mental retardation cases in the population.

Download full-text

Full-text

Available from: Alexander Hoischen
  • Source
    • "Distribution of vesicles and organelles by cytoskeletal motors plays a key role in neuronal function (Millecamps and Julien, 2013). The importance of cytoskeletal transport is underscored by the discovery of causative mutations in microtubule motor proteins and their cofactors in several human neurological disorders (Bi et al., 2009; Lipka et al., 2013; Puls et al., 2003; Reid et al., 2002; Vissers et al., 2010; Yamada et al., 2003; Zhao et al., 2001). Mitochondria have a central role in cellular homeostasis, with roles including the production of ATP and reactive oxygen species, buffering levels of Ca 2+ ions and regulating apoptosis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Defective transport of mitochondria in axons is implicated in the pathogenesis of several age-associated neurodegenerative diseases. However, the regulation and function of axonal mitochondrial motility during normal ageing is poorly understood. Here, we use novel imaging procedures to characterise axonal transport of these organelles in the adult Drosophila wing nerve. During early adult life there is a boost and progressive decline in the proportion of mitochondria that are motile, which is not due to general changes in cargo transport. Experimental inhibition of mitochondrial transport specifically in adulthood accelerates the appearance of focal protein accumulations in ageing axons, suggestive of defects in protein homeostasis. Unexpectedly, lowering levels of Lissencephaly-1 (Lis1), a dynein motor co-factor, augments axonal mitochondrial transport in ageing wing neurons. Lis1 mutations suppress focal protein accumulations in ageing neurons, including those caused by interfering with the mitochondrial transport machinery. Our data provide new insights into the dynamics of mitochondrial motility in adult neurons in vivo, identify Lis1 as a negative regulator of transport of these organelles and provide evidence of a link between mitochondrial movement and neuronal protein homeostasis.
    Preview · Article · Nov 2015 · Journal of Cell Science
  • Source
    • ". Mutations of the RAB39B gene associated with X-linked intellectual disability (Andersen et al., 2014; Giannandrea et al., 2010; Vissers et al., 2010; Wilson et al., 2014). Asterisks designate mutations identified in patients with X-linked intellectual disability and Parkinson's disease. "

    Full-text · Dataset · Oct 2015
  • Source
    • "As the quality of antenatal and postnatal care improves, the genetic contribution to intellectual disability (ID) becomes ever more significant and has emerged as the commonest phenotypic manifestation of a constitutional genomic abnormality [Ropers, 2010]. ID is prevalent, despite severely reducing fecundity, due to a high de novo mutation rate in a wide range of genes leading to rare Mendelian diseases [Vissers et al., 2010]. Strategies to identify novel disease causing genes have successfully used de novo trio analysis to compare the proband's genome against the parental genomes with a diagnostic rate of 15%–40% [de Ligt et al., 2012; Rauch et al., 2012; Gilissen et al., 2014; Hamdan et al., 2014; The Deciphering Developmental Disorders Study, 2014] and a further 10%–20% diagnostic rate using a homozygosity mapping or biallelic variant analysis strategy [Musante and Ropers, 2014]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To identify genetic causes of intellectual disability (ID), we screened a cohort of 986 individuals with moderate to severe ID for variants in 565 known or candidate ID-associated genes using targeted next-generation sequencing. Likely pathogenic rare variants were found in ∼11% of the cases (113 variants in 107/986 individuals: ∼8% of the individuals had a likely pathogenic loss of function (LoF) variant, while ∼3% had a known pathogenic missense variant). Variants in SETD5, ATRX, CUL4B, MECP2 and ARID1B were the most common causes of ID. This study assessed the value of sequencing a cohort of probands to provide a molecular diagnosis of ID, without the availability of DNA from both parents for de novo sequence analysis. This modelling is clinically relevant as 28% of all UK families with dependent children are single parent households. In conclusion, to diagnose patients with ID in the absence of parental DNA, we recommend investigation of all LoF variants in known genes that cause ID and assessment of limited list of proven pathogenic missense variants in these genes. This will provide 11% additional diagnostic yield beyond the 10-15% yield from array CGH alone. This article is protected by copyright. All rights reserved.
    Full-text · Article · Sep 2015 · Human Mutation
Show more